Progressive Supranuclear Palsy (psp) Clinical Trials
2 recruiting trials for Progressive Supranuclear Palsy (psp). Eligibility criteria explained in plain English.
TrialFinderData lists 2 Progressive Supranuclear Palsy (psp) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Mayo Clinic (1), Centre Hospitalier Universitaire de Liege (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Syde (device, 1 trial), followed by Dynamometric measurements of muscle strength, The 6-minute walk test (6MWT).
Track Progressive Supranuclear Palsy (psp) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) represents the formalized integration of ARTFL (U54 NS092089; funded through 2019) and LEFFTDS (U01 AG045390;...
Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology
The ActiLiège-Adult study is a prospective, longitudinal, observational study designed to collect natural history data on adult patients with neurological or metabolic diseases...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Progressive Supranuclear Palsy (psp), with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Progressive Supranuclear Palsy (psp), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Progressive Supranuclear Palsy (psp), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.